OTCMKTS:EMHTF Emerald Health Therapeutics (EMHTF) Stock Price, News & Analysis $0.04 +0.01 (+55.17%) (As of 11/11/2022) Add Compare Share Share Today's Range$0.03▼$0.0450-Day Range$0.04▼$0.0452-Week Range$0.02▼$0.09Volume1.05 million shsAverage Volume116,962 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Emerald Health Therapeutics alerts: Email Address Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. About Emerald Health Therapeutics Stock (OTCMKTS:EMHTF)Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.Read More EMHTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EMHTF Stock News HeadlinesAugust 21, 2024 | finance.yahoo.comViking Therapeutics, Inc. (VKTX)February 16, 2024 | npr.orgShotsSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. October 6, 2023 | health.usnews.comEmerald D. RobinsonJanuary 12, 2023 | finance.yahoo.comEmerald Health Pharmaceuticals Receives Safety Review Committee Approval to Proceed to Final Cohorts of EHP-101 Phase 2a Systemic Sclerosis TrialNovember 9, 2022 | finance.yahoo.comIIROC Trading Halt - EMHNovember 7, 2022 | finance.yahoo.comEmerald Health Therapeutics and Skye Bioscience Announce Intended Closing Date of Plan of ArrangementSeptember 2, 2022 | seekingalpha.comEmerald Health Therapeutics Q2 GAAP EPS of -C$0.01, revenue of C$1.28MSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. August 23, 2022 | finance.yahoo.comHYTN Awarded Medical Cannabis Sales Licence Increasing Opportunities at Kelowna FacilityAugust 12, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Restates Q1 Financial Statements to Meet PCAOB StandardAugust 12, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Provides Update on and Additional Background to Transaction with Skye BioscienceJuly 13, 2022 | finanznachrichten.deEmerald Health Therapeutics, Inc.: Emerald Health Therapeutics Announces Revocation of Management Cease Trade OrderJuly 11, 2022 | nz.finance.yahoo.comEMERALD HEALTH SCIENCES INC.June 3, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Provides Second Bi-Weekly MCTO Status UpdateMay 12, 2022 | finance.yahoo.comEmerald Health Therapeutics Signs Arrangement Agreement with Skye BioscienceMay 6, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Transfers US Listing to OTCQBApril 28, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Applies for Management Cease Trade OrderSee More Headlines Receive EMHTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorOils/Energy Industry Oil & Gas Production Sub-IndustryN/A Current SymbolOTCMKTS:EMHTF CUSIPN/A CIK1768225 Webwww.emerald.care Phone(800) 757-3536FaxN/AEmployees110Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Mohammed JiwanChief Operating OfficerMr. Bernie HertelVP of Fin. and CommunicationsMs. Rebecca WongSr. VP of Quality & Regulatory AffairsKey CompetitorsGASFRAC Energy ServicesOTCMKTS:GSFVFLeucrotta ExplorationOTCMKTS:LCRTFSeven Generations EnergyOTCMKTS:SVRGFSpyglass ResourcesOTCMKTS:PACEFTORC Oil & GasOTCMKTS:VREYFView All Competitors EMHTF Stock Analysis - Frequently Asked Questions How have EMHTF shares performed this year? Emerald Health Therapeutics' stock was trading at $0.0405 at the start of the year. Since then, EMHTF shares have increased by 0.0% and is now trading at $0.0405. View the best growth stocks for 2024 here. How do I buy shares of Emerald Health Therapeutics? Shares of EMHTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EMHTF) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emerald Health Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emerald Health Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EMHTF Stock Alerts